Literature DB >> 9559926

Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production.

D T Laskowitz1, W D Matthew, E R Bennett, D Schmechel, M H Herbstreith, S Goel, M K McMillian.   

Abstract

The human apolipoprotein (apo) E4 isoform is associated with an increased risk for Alzheimer's disease (AD) and poor prognosis after acute CNS injury. Addition of human apoE inhibits murine microglial activation in culture, suggesting that microglia might be an important physiological target of apoE. In the present study, we examined the role of endogenous murine apoE in modulating microglial nitric oxide (NO) production following lipopolysaccharide (LPS) stimulation. Brain cultures from apoE-deficient mouse pups showed enhanced NO production relative to cultures from wild-type mice and from transgenic mice expressing the human apoE3 isoform, demonstrating that endogenous apoE produced by glial cultures is capable of inhibiting microglial function. ApoE produced within the brain may suppress microglial reactivity and thus alter the CNS response to acute and chronic injury.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559926     DOI: 10.1097/00001756-199803090-00010

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

1.  Low-density lipoprotein receptors regulate microglial inflammation through c-Jun N-terminal kinase.

Authors:  Ana Pocivavsek; Mark P Burns; G William Rebeck
Journal:  Glia       Date:  2009-03       Impact factor: 7.452

Review 2.  The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis.

Authors:  Hong-liang Zhang; Jiang Wu; Jie Zhu
Journal:  J Biomed Biotechnol       Date:  2010-02-16

Review 3.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

4.  Genetic risk factors for perinatal arterial ischemic stroke.

Authors:  Amy A Gelfand; Lisa A Croen; Anthony R Torres; Yvonne W Wu
Journal:  Pediatr Neurol       Date:  2013-01       Impact factor: 3.372

5.  Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation.

Authors:  Patricia G Yancey; John Blakemore; Lei Ding; Daping Fan; Cheryl D Overton; Youmin Zhang; MacRae F Linton; Sergio Fazio
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-11       Impact factor: 8.311

6.  APOE genotype alters glial activation and loss of synaptic markers in mice.

Authors:  Yuangui Zhu; Evelyn Nwabuisi-Heath; Sonya B Dumanis; Leon M Tai; Chunjiang Yu; G William Rebeck; Mary Jo LaDu
Journal:  Glia       Date:  2012-01-06       Impact factor: 7.452

Review 7.  ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.

Authors:  Arlene M Manelli; W Blaine Stine; Linda J Van Eldik; Mary Jo LaDu
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

8.  Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation.

Authors:  Ana Pocivavsek; Irina Mikhailenko; Dudley K Strickland; G William Rebeck
Journal:  J Neuroimmunol       Date:  2009-07-07       Impact factor: 3.478

9.  Apolipoprotein E modifies neurological outcome by affecting cerebral edema but not hematoma size after intracerebral hemorrhage in humans.

Authors:  Michael L James; Robert Blessing; Ellen Bennett; Daniel T Laskowitz
Journal:  J Stroke Cerebrovasc Dis       Date:  2009 Mar-Apr       Impact factor: 2.136

10.  Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors.

Authors:  Ling Liu; Orwa Aboud; Richard A Jones; Robert E Mrak; W Sue T Griffin; Steven W Barger
Journal:  J Neuroinflammation       Date:  2011-12-15       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.